Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 1
2006 2
2007 1
2009 1
2010 4
2011 4
2012 3
2013 6
2014 13
2015 12
2016 6
2017 4
2018 7
2019 9
2020 5
2021 13
2022 7
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Outcomes in patients with BRAFV600-mutated melanoma and brain metastases at baseline treated with dabrafenib plus trametinib.
Aglietta M, Chiarion-Sileni V, Fava P, Guidoboni M, Depenni R, Minisini A, Consoli F, Ascierto PA, Rinaldi G, Banzi M, Marconcini R, Gueli R, Ferraresi V, Tucci M, Tonini G, Lo Re G, Guida M, Del Vecchio M, Marcon IG, Queirolo P. Aglietta M, et al. Among authors: lo re g. Tumori. 2023 Dec;109(6):537-545. doi: 10.1177/03008916231179251. Epub 2023 Jul 7. Tumori. 2023. PMID: 37417313 Free PMC article.
Current Trends in Mucosal Melanomas: An Overview.
Santeufemia DA, Palmieri G, Miolo G, Colombino M, Doro MG, Frogheri L, Paliogiannis P, Capobianco G, Madonia M, Cossu A, Lo Re G, Corona G. Santeufemia DA, et al. Among authors: lo re g. Cancers (Basel). 2023 Feb 21;15(5):1356. doi: 10.3390/cancers15051356. Cancers (Basel). 2023. PMID: 36900152 Free PMC article. Review.
Integrating conventional and complementary treatments in cancer care: The process within the public healthcare system of the region of Tuscany, Italy.
Giovanni RE, Francesca B, Anna N, Cristina N, Marco P, Linda N, Pasquale GC, Fabio F, Rosaria F, Franco C, Mariella DS, Tommaso C, Chiara M, Irene S, Sonia B, Luigi S, Filippo B, Francesca M, Cristina P, Alessandra S, Enrico T, Gianni A. Giovanni RE, et al. Complement Ther Clin Pract. 2023 May;51:101738. doi: 10.1016/j.ctcp.2023.101738. Epub 2023 Feb 18. Complement Ther Clin Pract. 2023. PMID: 36812736 No abstract available.
Concomitant Drugs Prognostic Score in Patients With Metastatic Renal Cell Carcinoma Receiving Ipilimumab and Nivolumab in the Compassionate Use Program in Italy: Brief Communication.
Buti S, Basso U, Giannarelli D, De Giorgi U, Maruzzo M, Iacovelli R, Galli L, Porta C, Carrozza F, Procopio G, Fonarini G, Lo Re G, Santoni M, Sabbatini R, Cusmai A, Zucali PA, Aschele C, Baldini E, Zafarana E, Favaretto A, Leo S, Hamzaj A, Mirabelli R, Nole' F, Zai S, Chini C, Masini C, Fatigoni S, Rocchi A, Tamburini E, Cortellini A, Bersanelli M. Buti S, et al. Among authors: lo re g. J Immunother. 2023 Jan 1;46(1):22-26. doi: 10.1097/CJI.0000000000000446. Epub 2022 Nov 4. J Immunother. 2023. PMID: 36472582 Free PMC article.
89 results